Opinion of the Transparency Council – amendments to PL B.59 on melanoma of the skin or mucous membranes
At its Meeting on 27 June 2022, the Transparency Council adopted Opinion No. 98/2022 on changes to the drug programme B.59: “Treatment of melanoma of the skin or mucous membranes (ICD-10 C43)”.
Publication with the minutes of the Transparency Council meeting